June 8, 2015
With a high sensitivity for detecting disease recurrence, follow-up imaging using PET/CT may help to more successfully guide the management of patients with non-Hodgkin lymphoma (NHL) who are at risk for disease recurrence, according to the results of a study presented during the 2015 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (abstract 599).
“A permanent cure may still be achieved using salvage chemotherapy, but early diagnosis of a relapse is essential,” study author Mehdi Taghipour, MD, a research fellow from the department of radiology at the Johns Hopkins Medical Institutions, said in a prepared statement. “PET/CT imaging is superior to conventional imaging for NHL, but the role of post-treatment PET/CT has been controversial. Our study proves that 39% of follow-up PET/CT scans added clinical value, which represents a significant improvement in NHL patient care.”Full Story